DD129784A5 - Verfahren zur herstellung von neuen iminoverbindungen - Google Patents

Verfahren zur herstellung von neuen iminoverbindungen

Info

Publication number
DD129784A5
DD129784A5 DD7700197567A DD19756777A DD129784A5 DD 129784 A5 DD129784 A5 DD 129784A5 DD 7700197567 A DD7700197567 A DD 7700197567A DD 19756777 A DD19756777 A DD 19756777A DD 129784 A5 DD129784 A5 DD 129784A5
Authority
DD
German Democratic Republic
Prior art keywords
iminover
bindings
producing new
producing
new
Prior art date
Application number
DD7700197567A
Other languages
English (en)
Inventor
Atso Ilvespaeae
Walter Fuhrer
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD129784A5 publication Critical patent/DD129784A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22Radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/04Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD7700197567A 1976-02-27 1977-02-25 Verfahren zur herstellung von neuen iminoverbindungen DD129784A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH244176 1976-02-27

Publications (1)

Publication Number Publication Date
DD129784A5 true DD129784A5 (de) 1978-02-08

Family

ID=4233883

Family Applications (1)

Application Number Title Priority Date Filing Date
DD7700197567A DD129784A5 (de) 1976-02-27 1977-02-25 Verfahren zur herstellung von neuen iminoverbindungen

Country Status (22)

Country Link
US (2) US4130652A (de)
JP (1) JPS52105167A (de)
AT (1) AT361463B (de)
AU (1) AU515046B2 (de)
BE (1) BE851812A (de)
CA (1) CA1085413A (de)
CS (2) CS192600B2 (de)
DD (1) DD129784A5 (de)
DE (1) DE2707658A1 (de)
DK (1) DK82877A (de)
ES (1) ES456296A1 (de)
FI (1) FI770346A (de)
FR (1) FR2342285A1 (de)
GB (1) GB1574921A (de)
IL (1) IL51549A (de)
NL (1) NL7701885A (de)
NO (1) NO770655L (de)
NZ (1) NZ183426A (de)
PL (1) PL108099B1 (de)
PT (1) PT66236B (de)
SE (1) SE7702106L (de)
ZA (1) ZA771129B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2252536C (en) * 1996-04-25 2010-04-06 Nissan Chemical Industries, Ltd. Ethylene derivatives and pesticides containing said derivatives
FR2751969B1 (fr) 1996-08-01 1998-12-04 Centre Nat Rech Scient Composes activateurs du canal cftr, et compositions pharmaceutiques les contenant
KR20010108050A (ko) 1998-12-25 2001-12-07 도쿠시마 히데이치 아크릴로니트릴 화합물
JP2008508427A (ja) 2004-07-30 2008-03-21 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 原子層蒸着による銅フィルムの蒸着のための銅(ii)錯体
US20070191638A1 (en) * 2006-02-10 2007-08-16 Park Kyung-Ho Processes for the synthesis of N,N'-substituted 1,3-diketimines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7111141A (de) * 1970-08-17 1972-02-21
FR2190818B1 (de) * 1972-06-28 1975-03-07 Roussel Uclaf
US3890445A (en) * 1973-01-05 1975-06-17 Richardson Merrell Inc Lactamimide derivatives useful as hypoglycemic agents
US3840524A (en) * 1973-04-25 1974-10-08 Richardson Merrell Inc Alpha-cycloalkylbenzyl lactamimides

Also Published As

Publication number Publication date
PL196269A1 (pl) 1978-10-23
BE851812A (fr) 1977-08-25
IL51549A0 (en) 1977-04-29
ES456296A1 (es) 1978-02-01
JPS52105167A (en) 1977-09-03
PT66236B (en) 1978-07-17
DK82877A (da) 1977-08-28
PL108099B1 (pl) 1980-03-31
ATA127977A (de) 1980-08-15
US4251542A (en) 1981-02-17
AU2268677A (en) 1978-08-31
FR2342285A1 (fr) 1977-09-23
GB1574921A (en) 1980-09-10
FI770346A (de) 1977-08-28
NO770655L (no) 1977-08-30
NL7701885A (nl) 1977-08-30
IL51549A (en) 1980-03-31
ZA771129B (en) 1978-01-25
PT66236A (en) 1977-03-01
AT361463B (de) 1981-03-10
CS192600B2 (en) 1979-08-31
SE7702106L (sv) 1977-08-28
CA1085413A (en) 1980-09-09
US4130652A (en) 1978-12-19
AU515046B2 (en) 1981-03-12
DE2707658A1 (de) 1977-09-01
FR2342285B1 (de) 1980-01-11
NZ183426A (en) 1979-10-25
CS192574B2 (en) 1979-08-31

Similar Documents

Publication Publication Date Title
AT356827B (de) Verfahren zur herstellung von neuen spirol- actonen
AT358727B (de) Verfahren zur herstellung von neuen cephalos- porinantibiotika
AT356136B (de) Verfahren zur herstellung von neuen spiro- hydantoinen
AT363478B (de) Verfahren zur herstellung von neuen oxepanderivaten
AT359187B (de) Verfahren zur herstellung von neuen 7-beta-(2- -oxyimino-2-arylacetamido)-cephalosporinen
AT370110B (de) Verfahren zur herstellung von neuen 4-androsten-3-onen
AT360185B (de) Verfahren zur herstellung von neuen dehydro- digopeptiden
AT350537B (de) Verfahren zur herstellung von neuen benzyl- cyanoacetalen
AT361638B (de) Verfahren zur herstellung von neuen dimeren indoldihydroindoldionen
DD129784A5 (de) Verfahren zur herstellung von neuen iminoverbindungen
AT362786B (de) Verfahren zur herstellung von neuen 1-acyl-2-imidazolinen
AT358726B (de) Verfahren zur herstellung von neuen cephalos- porinantibiotika
AT360037B (de) Verfahren zur herstellung von neuen substi- tuierten phenylguanidinen
AT351191B (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT375931B (de) Verfahren zur herstellung von neuen aminoalkylfuranderivaten
AT364364B (de) Verfahren zur herstellung von neuen thiepinen
AT343623B (de) Verfahren zur herstellung von neuen n-alkyl -4-nitro-2- trifluormethyldiphenylaminen
AT360646B (de) Verfahren zur herstellung von neuen cephalos- porinen
ATA175879A (de) Verfahren zur herstellung von neuen antitumorglycosiden
ATA656076A (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT351515B (de) Verfahren zur herstellung von neuen polyenver- bindungen
AT355039B (de) Verfahren zur herstellung von neuen veraetherten hydroxy-benzimidazolonen, - benzoxazolonen, -benzoxazinonen,- china- zolinonen und -chinoxazolinonen
AT355210B (de) Verfahren zur herstellung von neuen 1-oxa- dethiacephalosporinen
AT364367B (de) Verfahren zur herstellung von neuen oxepinen
ATA208580A (de) Verfahren zur herstellung von neuen d-homosteroiden